GROUP A | GROUP B | GROUP C | p value | |
---|---|---|---|---|
(n = 52) | (n = 53) | (n = 52) | ||
Number of infected patients | 18/52 (34.6 %) | 23/53 (43.4 %) | 23/52 (44.2 %) | 0.54 |
Odds ratio | 1.4 (0.6–3.1)a | 1.03 (0.4–2.2)c | ||
1.4 (0.6–3.3)b | ||||
Infectious complication incidence rate / % treatment days | 22/546 (4.03) | 24/470 (5.11) | 24/505 (4.75) | 0.51 |
Catheter-related bloodstream infection | 1/52 (1.92 %) | 1/53 (1.89 %) | 2/52 (3.85 %) | 0.53 |
Primary bloodstream infection | 3/52 (5.77 %) | 1/53 (1.89 %) | 3/52 (5.77 %) | 0.25 |
UTI | 1/52 (1.92 %) | 1/53 (1.89 %) | 1/52 (1.92 %) | 1.00 |
Tracheobronchitis incidence rate / 1000 ventilator days | 7/460 (15.2)*a | 10/392 (25.5) | 7/424 (16.5)*c | <0.01* |
VAP incidence rate / 1000 ventilator days | 8/460 (17.3)*a | 10/392 (25.5) | 6/424 (14.1)*c | <0.05*a |
< 0.01*c |